{reportSlug=global-immuno-oncology-drugs-market, reportId=87432, mktKeyword=Immuno-oncology Drugs, cagr=20.30, publishDate=Mar 2024, priceOption2=6800, reportTitle=Immuno-oncology Drugs Comprehensive Study by Type (Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy), Application (Hospitals, Pharmacies, Online Pharmacies), Therapies (Iplimumab, Nivolumab, Rituximab, Blinatumomab, Aldesleukin, Recombinant human papillomavirus vaccine (Gardasil), Tisagenlecleucel (Kymriah)), Sales Channel (Direct, Indirect) Players and Region - Global Market Outlook to 2030, baseYr=2023, totalTableFig=187, priceOption1=3750, forecastYr=2030, noOfPages=203, reportKey=86991, breadcrum=Global Immuno-oncology Drugs Market}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Mar 2024
203 Pages
74 Tables
Base Year: 2023Coverage: 15+ Companies; 18
Countries